drugset / Trial / NCT04820049

F573 Ia Clinical Trial

NCT04820049 ↗

Phase 1 Completed 100 enrolled Beijing Continent Pharmaceutical Co, Ltd.
RandomizedParallel-groupSingle-blindOther

Summary

Tolerance and PK study of F573

Timeline

Start
2021-02-08
Primary completion
2022-08-02
Completion
2022-11-06

Drugs

EvaluationDrugModalityDoseRoute
Subject F573 Unknown — —

Indications

No indication recorded.